Literature DB >> 14633555

The effects of vasopressin on systemic and splanchnic hemodynamics and metabolism in endotoxin shock.

Tero J Martikainen1, Jyrki J Tenhunen, Ari Uusaro, Esko Ruokonen.   

Abstract

UNLABELLED: We compared the effects of vasopressin and norepinephrine on systemic and splanchnic circulation and metabolism in endotoxin shock in pigs. Twenty-one pigs were randomized to endotoxin shock (Escherichia coli endotoxin infusion) (n = 6), endotoxin and vasopressin (VASO; n = 6), endotoxin and norepinephrine (NE; n = 6), and controls (n = 3). Endotoxin infusion was increased to induce hypotension, after which vasopressin or norepinephrine was started to keep systemic mean arterial blood pressure >70 mm Hg. Regional blood flows and arterial and regional lactate concentrations were measured. Tonometers with microdialysis capillaries were inserted into the stomach, jejunum, and colon. Systemic mean arterial blood pressure >70 mm Hg was achieved in the VASO and NE groups. Vasopressin decreased cardiac output, superior mesenteric artery, and portal vein blood flow, whereas hepatic arterial blood flow increased. Arterial lactate concentration increased from 2.0 mM (1.6-2.1 mM) to 4.7 mM (4.7-4.9 mM) (P = 0.007). Systemic and mesenteric oxygen delivery and consumption decreased and oxygen extraction increased in the VASO group. Vasopressin increased mucosal-arterial PCO(2) gradients in all three locations, whereas luminal lactate release occurred only in the jejunum. Animals in the NE group remained stable. Vasopressin reversed hypotension but decreased systemic and gut blood flow. This was associated with hyperlactatemia, signs of visceral dysoxia, and jejunal luminal lactate release. IMPLICATIONS: Although vasopressin induces vasoconstriction in visceral region, its effects on splanchnic circulation and metabolism during septic-endotoxin shock are still poorly characterized. We evaluated the metabolic and hemodynamic effects of vasopressin and norepinephrine within the splanchnic area in porcine endotoxin shock.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14633555     DOI: 10.1213/01.ane.0000087039.60041.2e

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  24 in total

1.  Vasopressin and splanchnic blood flow: vasoconstriction does not equal vasoconstriction in every organ.

Authors:  P Asfar; P Radermacher; B Hauser
Journal:  Intensive Care Med       Date:  2005-11-18       Impact factor: 17.440

2.  Vasopressin as adjunct vasopressor for vasodilatory shock due to non-occlusive mesenteric ischemia.

Authors:  G Luckner; S Jochberger; V D Mayr; H Knotzer; W Pajk; V Wenzel; B Friesenecker; I Lorenz; M W Dünser
Journal:  Anaesthesist       Date:  2006-03       Impact factor: 1.041

3.  Arginine vasopressin does not alter mucosal tissue oxygen tension and oxygen supply in an acute endotoxemic pig model.

Authors:  Hans Knotzer; Stephan Maier; Martin W Dünser; Walter R Hasibeder; Hans Hausdorfer; Julia Brandner; Christian Torgersen; Hanno Ulmer; Barbara Friesenecker; Claudia Iannetti; Werner Pajk
Journal:  Intensive Care Med       Date:  2005-11-18       Impact factor: 17.440

Review 4.  Use of inotropes and vasopressor agents in critically ill patients.

Authors:  Mansoor N Bangash; Ming-Li Kong; Rupert M Pearse
Journal:  Br J Pharmacol       Date:  2012-04       Impact factor: 8.739

5.  Comparison of the effects of vasopressin and norepinephrine on organ perfusion during septic shock in streptozotocin-induced diabetic rats.

Authors:  Hiroshi Hinohara; Yuji Kadoi; Aya Tokue; Shigeru Saito; Chikara Kawauchi; Akio Mizutani
Journal:  J Anesth       Date:  2010-08       Impact factor: 2.078

Review 6.  Vasopressin for treatment of vasodilatory shock: an ESICM systematic review and meta-analysis.

Authors:  Angelo Polito; Emilio Parisini; Zaccaria Ricci; Sergio Picardo; Djillali Annane
Journal:  Intensive Care Med       Date:  2011-11-30       Impact factor: 17.440

7.  Prolonged hypervolemic hemodilution decreases functional capillary density of ileal mucosa in pigs revealed by sidestream dark-field imaging.

Authors:  Zdenek Turek; Vladimir Cerny; Renata Parizkova; Jindrich Samek; Martin Oberreiter
Journal:  J Zhejiang Univ Sci B       Date:  2011-10       Impact factor: 3.066

8.  Comparison of cardiac, hepatic, and renal effects of arginine vasopressin and noradrenaline during porcine fecal peritonitis: a randomized controlled trial.

Authors:  Florian Simon; Ricardo Giudici; Angelika Scheuerle; Michael Gröger; Pierre Asfar; Josef A Vogt; Ulrich Wachter; Franz Ploner; Michael Georgieff; Peter Möller; Régent Laporte; Peter Radermacher; Enrico Calzia; Balázs Hauser
Journal:  Crit Care       Date:  2009-07-10       Impact factor: 9.097

9.  Vasopressin treatment of verapamil toxicity in the porcine model.

Authors:  J Dave Barry; Dave Durkovich; Lee Cantrell; William Richardson; Tri Tong; Steve Offerman; Richard F Clark; David A Tanen; Saralyn Williams
Journal:  J Med Toxicol       Date:  2005-12

Review 10.  Vasopressin vs. terlipressin in the treatment of cardiovascular failure in sepsis.

Authors:  Matthias Lange; Christian Ertmer; Martin Westphal
Journal:  Intensive Care Med       Date:  2007-12-08       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.